Vera Therapeutics Inc Cl A (VERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -230,505 | -121,032 | -299,615 | -208,518 | -128,225 |
| Depreciation Amortization | -384 | -64 | -4,656 | -4,319 | -3,840 |
| Accounts payable and accrued liabilities | -7,302 | -7,966 | 13,910 | 10,285 | 5,492 |
| Other Working Capital | -20,171 | -13,728 | 22,992 | 12,630 | 3,944 |
| Other Operating Activity | 51,609 | 36,290 | 26,265 | 18,812 | 13,425 |
| Operating Cash Flow | $-206,753 | $-106,500 | $-241,104 | $-171,110 | $-109,204 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -23 | -23 | -630 | -528 | -395 |
| Purchase Of Investment | -308,617 | -210,561 | -310,446 | -285,947 | -187,251 |
| Sale Of Investment | 218,948 | 87,918 | 506,162 | 400,897 | 232,307 |
| Purchase Sale Intangibles | -264 | -150 | N/A | N/A | N/A |
| Other Investing Activity | -15,264 | -15,150 | -800 | -800 | -800 |
| Investing Cash Flow | $-104,956 | $-137,816 | $194,286 | $113,622 | $43,861 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,860 | 3,942 | 306,981 | 2,794 | 1,997 |
| Other Financing Activity | 0 | 0 | 1,916 | 19,821 | 19,821 |
| Financing Cash Flow | $5,860 | $3,942 | $308,897 | $22,615 | $21,818 |
| Beginning Cash Position | 354,725 | 354,725 | 92,646 | 92,646 | 92,646 |
| End Cash Position | 48,876 | 114,351 | 354,725 | 57,773 | 49,121 |
| Net Cash Flow | $-305,849 | $-240,374 | $262,079 | $-34,873 | $-43,525 |
| Free Cash Flow | |||||
| Operating Cash Flow | -206,753 | -106,500 | -241,104 | -171,110 | -109,204 |
| Capital Expenditure | -23 | -23 | -630 | -528 | -395 |
| Free Cash Flow | -206,776 | -106,523 | -241,734 | -171,638 | -109,599 |